Do I need blood tests while on HRT?

Routine hormone blood tests are generally not required for women on standard, FDA-approved HRT, though specific circumstances may call for laboratory monitoring. A prescriber should determine whether testing is appropriate based on a patient's complete medical history.

Why blood tests are usually not needed

According to current NAMS guidelines, hormone blood levels fluctuate significantly throughout the day, making a single measurement an unreliable indicator of whether a dose is appropriate. Per published clinical guidelines, the primary basis for dose adjustment in most women is symptom response — including changes in hot flashes, sleep quality, mood, and vaginal dryness — rather than laboratory values.

Per FDA-approved prescribing information, standard doses of estrogen and progesterone used in HRT have established pharmacological profiles, and clinicians typically guide adjustments based on tolerability and symptom control rather than serum levels alone.

When blood tests can be helpful

• Unusual or persistent symptoms: If symptoms do not respond to dose adjustments, a clinician may order laboratory testing to assess whether the medication is being adequately absorbed.
• Use of custom-compounded preparations or pellets: According to current NAMS guidelines, absorption of compounded formulations can vary considerably between individuals, and periodic monitoring may assist in dose optimization. Compounded medications are not FDA-approved. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved medications should be considered first when commercially available options meet patient needs.
• Testosterone therapy: Per the Endocrine Society, when testosterone is prescribed for low libido or fatigue, serum levels are monitored to avoid supraphysiologic concentrations.
• Thyroid or adrenal conditions: According to ACOG, thyroid function and related parameters may shift modestly after estrogen initiation in women with pre-existing thyroid or adrenal conditions, warranting periodic evaluation.

What tests are still recommended on HRT (not hormone levels)

• Mammogram: Current screening schedules — typically every 1–2 years — should be maintained per standard preventive care recommendations.
• Blood pressure: Annual monitoring is recommended, as estrogen may have modest effects on blood pressure in some individuals.
• Lipid panel: Per published clinical guidelines, cholesterol monitoring may be indicated, particularly for women with cardiovascular risk factors.
• Endometrial evaluation: According to ACOG, evaluation by ultrasound or biopsy may be indicated if unexpected postmenopausal bleeding occurs.

Summary

According to current NAMS guidelines, routine hormone level testing is not a standard requirement for most women on HRT; symptom-based monitoring is the primary approach in clinical practice. Laboratory testing is reserved for situations where absorption, tolerability, or a concurrent condition warrants closer evaluation. Whether HRT monitoring — including any laboratory testing — is appropriate depends on individual health factors. A prescriber should determine the best approach based on a patient's complete medical history.